Pharmacokinetic-interaction of Vitex negundo Linn. & paracetamol

Indian Journal of Medical Research

Volumn 130, Issue 4, 2009, Pages 479-483

  Tripathi, Yamini Bhusan ^a   Tiwari, Om Prakash ^a   Nagwani, Santosh ^a   Mishra, Brahmeshwar ^b  

^a BANARAS HINDU UNIVERSITY   (India)

^b BANARAS HINDU UNIVERSITY   (India)

Author keywords

Bioavailability; Herb drug interaction; Paracetamol; Pharmacokinetics; Vitex negundo

Indexed keywords

PARACETAMOL; VITEX NEGUNDO EXTRACT;

ANIMAL EXPERIMENT; AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG ANTAGONISM; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG DOSE INCREASE; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MALE; MAXIMUM PLASMA CONCENTRATION; NONHUMAN; RAT; TIME TO MAXIMUM PLASMA CONCENTRATION;

ACETAMINOPHEN; ANALGESICS, NON-NARCOTIC; ANIMALS; AREA UNDER CURVE; DRUG INTERACTIONS; ETHANOL; FEMALE; MALE; MEDICINE, AYURVEDIC; PLANT EXTRACTS; PLANT LEAVES; PLANT PREPARATIONS; RANDOM ALLOCATION; RATS; VITEX;

EID: 71449114755     PISSN: 09715916     EISSN: 09715916     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Catherine CC, Thomas NW. Use of herbal medicines among consultation-liaison populations: A review of current information regarding risks, interactions, and efficacy. Psychosomatics 1998; 39: 3-13.
2. Eisenberg DM, Kessler RC, Foster C. Unconventional medicine in the United States. N Engl J Med 1993; 328: 246-52.
3. Izzo AA, Ernst E. Interaction between herbal medicines and prescribed drugs: A systematic review. Drugs 2001; 61: 2163-75.
4. Roberts JR, Gracely EJ, Schoffstall JM. Advantage of highsurface-area charcoal for gastrointestinal decontamination in a human acetaminophen ingestion model. Acad Emerg Med 1997; 4: 167-74.
5. Gubbins PO, Berth KE. Drug absorption in gastrointestinal disease and surgery. Clinical pharmacokinetic and therapeutic implications. Clin Pharmacokinet 1991; 21: 431-47.
6. Cummings AJ, King ML, Martin BK. A kinetic study of drug elimination: the excretion of paracetamol and its metabolites in man. Br J Pharmacol Chemother 1967; 29: 150-7.
7. Canivenc-Lavier MC, Bentejac M, Millar M L, Leclerc J, Siess M H, Latruffe N, et al. Differential effects of nonhydroxylated flavonoids as inducers of cytochrome P4501A and 2B isozymes in rat liver. Toxicol Appl Pharmacol 1996; 136: 348-53.
8. Panday GS, Chunekar KC. Bhav prakash nighantu varanasi: Chaukhambha Bharati Academy; 1998. p. 344-5.
9. Sabnis M. Chemistry and pharmacology of ayurvedic medicinal plants, 1st ed. Varanasi: Chaukambha Amarbharati Prakashan; 2006. p. 363-6.
10. Anisuzzaman M, Rahman AHMM, Harun- Or- Rashid M, Naderuzzaman ATM, Islam AKMR. An etnobotanical study of Madhupur, Tangail. J Appl Sci Res 2007; 3: 519-30.
11. Dutta PK, Chowdhury S, Chakravarty AK, Achari B, Pakrashi SC. Studies on Indian medicinal plants-part LXXV: Nishindaside, a novel iridoid glycoside from Vitex negundo. Tetrahedron 1983; 39: 3067-72.
12. Banerji A, Chadha MS, Malshet VG. Isolation of 5 hydroxy 3,6,7,3',4'pentamethoxy flavone from Vitex negundo. Phytochemistry 1969; 8: 511-2.
13. Chopra RN, Nayar SL, Chopra IC. Glossary of Indian medicinal plants. 2nd ed. New Delhi: CSIR; 1958. p. 256.
14. Tiwari OP, Tripathi YB. Antioxidant properties of different fractions of Vitex negundo. Food Chem 2007; 100: 1170-6.
15. Li Y, Xiong Z, Li F. Determination of epimedin C in rat plasma by reversed-phase high-performance chromatography after oral administration of Herba Epimedii extract. J Chromatogr B 2005; 821: 235-9.
16. Peggy G, Sylvie S, Michel L, Georges H. Influence of simulated weightlessness on the pharmacokinetics of acetaminophen administered by the oral route: a study in the rat. Fundam Clin Pharmacol 2004; 18: 57-64.
17. Prodan M, Gere-Paszti E, Farkas O, Forgacs E. Validation and simultaneous determination of paracetamol and caffeine in pharmaceutical formulations by RP-HPLC. Anal Chem 2003; 48: 901-7
18. Gibaldi M, Perrier D. Pharmacokinetics. 2nd ed. New York: Marcel-Dekker; 1982.
19. Jun SC, Byung WJ, Youn CK. Enhanced paclitaxel bioavailability after oral administration of paclitaxel or prodrug to rats pretreated with quercetin. Eur J Pharmaceut Biopharmaceut 2004; 57: 313-8.